CML: A new combination therapy against resistant leukemia
CML: A new combination therapy against resistant leukemia (Vienna, 6.2.2024) In a new publication in the American Journal of Hematology, scientists at St. Anna Children’s Cancer Research Institute show a treatment option for chronic myeloid leukemia with highly resistant multiple mutations that have eluded previous therapies. Chronic myeloid leukemia (CML) is a slowly progressing cancer. It […]
CML: A new combination therapy against resistant leukemia Read More »















